Quantcast

Latest acidosis Stories

implantable device for diabetes
2014-08-13 02:00:37

ETH Zurich ETH Zurich researchers from the Department of Biosystems Science and Engineering (D-BSSE) in Basel have developed an implantable device that precisely monitors acid build-up in the body for people with diabetes and produces insulin if acidosis becomes a risk. Many human metabolic functions only run smoothly if the acid level in the body remains neutral and stable. For humans, normal blood pH values lie between 7.35 and 7.45. By way of comparison, an empty stomach is extremely...

2013-02-08 11:44:23

Dietary changes reduce metabolic acidosis and kidney injury in kidney disease patients Highlight: -Adding fruits and vegetables to the diet is an effective alternative to medication to reduce metabolic acidosis and kidney injury in late-stage chronic kidney disease. -Metabolic acidosis is a common complication of kidney disease. Adding fruits and vegetables to the diet may help protect the kidneys of patients with chronic kidney disease (CKD) with too much acid build-up, according...

2012-06-10 23:03:33

Forget Alkaline Water. pH Plus Tablets from LHN increase alkalinity and support a healthy body for individuals concerned about Acidosis. The product is being debuted on Amazon.Com for the first time. Tampa Bay, FL USA (PRWEB) June 09, 2012 Liberty Health Network, LLC announces the release of pH Plus Nutritional Supplement on Amazon.Com ACIDOSIS is a scary-sounding word. Perhaps that's because "Acidosis" (too much acid waste in our body), is considered by many researchers to be the basic...

2011-09-12 13:04:01

Controlling acid-base status could lead to novel treatment strategies New research shows that febrile seizures in children may be linked to respiratory alkalosis, indicated by elevated blood pH and low carbon dioxide levels caused by hyperventilation, and independent of the underlying infection severity. Febrile seizures were not observed in susceptible children with fevers brought on by gastroenteritis, suggesting that low blood pH levels (acidosis) may have a protective effect. Full...

2011-06-14 08:00:00

SAN DIEGO, June 14, 2011 /PRNewswire/ -- Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 2b study designed to evaluate the efficacy and safety of MP4OX treatment plus standard of care in severely injured trauma patients with lactic acidosis due to...

2010-10-26 07:00:00

SOUTH PLAINFIELD, N.J., Oct. 26 /PRNewswire/ -- PTC Therapeutics, Inc. today announced that it is expanding the development of ataluren, an investigational new drug, with the initiation of a Phase 2 clinical trial in nonsense mutation methylmalonic acidemia (nmMMA). MMA is a rare genetic disorder caused by deficiencies of crucial metabolic enzymes. Lack of these enzymes causes toxic levels of methylmalonic acid to accumulate in body fluids resulting in life-threatening metabolic...

2010-08-31 20:40:06

Study meets primary endpoint of reducing lactate levels in trauma patients treated with MP4OX Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients. During hemorrhagic shock, inadequate...

2010-08-31 08:00:00

SAN DIEGO, Aug. 31 /PRNewswire/ -- Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients. During hemorrhagic shock, inadequate perfusion of critical organs can lead to insufficient...

2010-06-29 14:30:00

SAN DIEGO, June 29 /PRNewswire/ -- Sangart, Inc., today announced that enrollment was completed in a Phase IIa clinical study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. Complete study results are expected, after follow up of outcomes in these patients, in the second half of 2010. "The hemorrhagic shock that results from severe trauma can cause organ dysfunction and even death," said Karim Brohi, global...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related